New algorithm aims to make insulin dosing safer for diabetes patients

NCT ID NCT07599982

Recruiting now Disease control Sponsor: DreaMed Diabetes Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 23, 2026 · Updated 3 times

Summary

This study is testing a new tool called MODI, which is a smart algorithm that helps people with diabetes figure out the right amount of insulin to take. About 100 adults with type 1 or type 2 diabetes will use the MODI system along with a continuous glucose monitor for 13 weeks. The main goal is to see if using MODI is safe and doesn't increase dangerous low blood sugar episodes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MODI insulin titration algorithm (a device that helps adjust insulin doses)
What this could lead to: If successful, this could provide a safer, easier way for people with diabetes to manage their insulin doses using a smart algorithm.
What could go wrong: This is an early-stage, single-arm trial with no comparison group, so results may not be definitive. The algorithm may not work well for all users or could lead to low blood sugar events.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES (T1D) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Insulin Resistance type 1 diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES (T1D) TYPE 2 DIABETES (T2D)

Contacts and locations

Locations

Diabetes & Endocrine Treatment Specialisits (DETS)
RECRUITING

Sandy City, Utah, 84093, United States
Henry Ford Health System
RECRUITING

Detroit, Michigan, 48202, United States
SUNY Upstate Medical Center
RECRUITING

Albany, New York, 12246, United States
Texas Diabetes & Endocrinology
RECRUITING

Austin, Texas, 78731, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.